Items related to Clinical Utility of Applying PGx and Deprescribing-Based...
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy - Hardcover
Synopsis
Polypharmacy is a necessary and important aspect of drug treatment; however, it becomes a challenge when the medication risks outweigh the benefits for an individual patient. Drug-drug interactions and the introduction of prescribing cascades are common features of polypharmacy, which can lead to ineffectiveness and increased risk of adverse drug reactions (ADR). Genes encoding CYP450 isozymes and other drug-related biomarkers have attracted considerable attention as targets for pharmacogenetic (PGx) testing due to their impact on drug metabolism and response. This Special Issue is devoted to explore the status and initiatives taken to circumvent ineffectiveness and to improve medication safety for polypharmacy patients. Specific areas include drug-drug interactions and consequences thereof in therapeutic management, including PK- and PD-profiling; the application of PGx-based guidance and/or decision tools for drug-gene and drug-drug gene interactions; medication reviews; development and application of deprescribing tools; and drivers and barriers to overcome for successful implementation in the healthcare system.
"synopsis" may belong to another edition of this title.
- PublisherMdpi AG
- Publication date2022
- ISBN 10 303655162X
- ISBN 13 9783036551623
- BindingHardcover
- LanguageEnglish
- Number of pages224
- EditorVermehren Charlotte, Westergaard Niels
Search results for Clinical Utility of Applying PGx and Deprescribing-Based...
Stock Image
Clinical Utility Of Applying Pgx And Deprescribing-Based Decision Support In Polypharmacy
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # 44904017-n
Quantity: Over 20 available
Stock Image
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Print on DemandSeller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 4 out of 5 stars
HRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L1-9783036551623
Quantity: Over 20 available
Stock Image
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. In. Seller Inventory # ria9783036551623_new
Quantity: Over 20 available
Stock Image
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Print on DemandSeller: PBShop.store US, Wood Dale, IL, U.S.A.
Seller rating 5 out of 5 stars
HRD. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L1-9783036551623
Quantity: Over 20 available
Stock Image
Clinical Utility Of Applying Pgx And Deprescribing-Based Decision Support In Polypharmacy
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
Condition: As New. Unread book in perfect condition. Seller Inventory # 44904017
Quantity: Over 20 available
Seller Image
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy (Hardback or Cased Book)
Seller: BargainBookStores, Grand Rapids, MI, U.S.A.
Seller rating 5 out of 5 stars
Hardback or Cased Book. Condition: New. Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy 1.51. Book. Seller Inventory # BBS-9783036551623
Quantity: 5 available
Stock Image
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Seller: California Books, Miami, FL, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # I-9783036551623
Quantity: Over 20 available
Stock Image
Clinical Utility Of Applying Pgx And Deprescribing-Based Decision Support In Polypharmacy
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # 44904017-n
Quantity: Over 20 available
Stock Image
Clinical Utility Of Applying Pgx And Deprescribing-Based Decision Support In Polypharmacy
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Seller rating 5 out of 5 stars
Condition: As New. Unread book in perfect condition. Seller Inventory # 44904017
Quantity: Over 20 available
Seller Image
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Print on DemandSeller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Polypharmacy is a necessary and important aspect of drug treatment; however, it becomes a challenge when the medication risks outweigh the benefits for an individual patient. Drug-drug interactions and the introduction of prescribing cascades are common features of polypharmacy, which can lead to ineffectiveness and increased risk of adverse drug reactions (ADR). Genes encoding CYP450 isozymes and other drug-related biomarkers have attracted considerable attention as targets for pharmacogenetic (PGx) testing due to their impact on drug metabolism and response. This Special Issue is devoted to explore the status and initiatives taken to circumvent ineffectiveness and to improve medication safety for polypharmacy patients. Specific areas include drug-drug interactions and consequences thereof in therapeutic management, including PK- and PD-profiling; the application of PGx-based guidance and/or decision tools for drug-gene and drug-drug gene interactions; medication reviews; development and application of deprescribing tools; and drivers and barriers to overcome for successful implementation in the healthcare system. Seller Inventory # 9783036551623
Quantity: 2 available